GoldBamboo.com - Knowledge is strong medicine
  

Teen Depression Awareness Project (TDAP) - Article


  Not Signed In - Sign In / Register






Postpartum Depression

Baby Blues


Clinical Trial: Teen Depression Awareness Project (TDAP)

This study is currently recruiting patients.

Sponsored by: RAND
Information provided by: RAND

Purpose

The main objective of this research project is to describe the impact of depression on adolescent and family functioning compared to that of healthy adolescents and to understand the impact of Feedback and Patient Activation (FPA) on teen and family decision-making regarding seeking care for depressive disorders.

Condition Treatment or Intervention Phase
Depression
 Behavior: Education
Phase I

MedlinePlus related topics:  Depression

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study

Official Title: Teen Depression Awareness Project

Further Study Details: 
Primary Outcomes: Receipt of Care
Expected Total Enrollment:  800

Study start: October 2003;  Expected completion: September 2006
Last follow-up: September 2006;  Data entry closure: September 2006

Background: Depressive disorders are common among adolescents, and efficacious treatments are available. However, few adolescents receive appropriate care, and the effects of these disorders on adolescents' functioning and family burden are not well understood. Documenting these effects could make identifying and treating adolescents with mental health problems a higher priority for providers and parents, and for the adolescents themselves, than it is now.

Primary care settings provide the most important opportunities to improve care for mood and anxiety disorders among adolescents, since most children and adolescents have some contact with a primary care provider each year for well-child visits, school physicals, or acute care. However, an ongoing trial of a quality improvement intervention for depressed adolescents in primary care settings (RAND's Youth Partners in Care study) suggests that there are significant barriers to implementing quality improvement protocols in primary care.

Study Goals: The main objective of this research is to build an empirical foundation for developing effective strategies to improve treatment of adolescent mood and anxiety disorders in primary care settings. Our specific goals are to:

1. Describe the impact of depression on adolescent and family functioning compared to that of healthy adolescents.

2. Evaluate the effect of two interventions--depression diagnosis feedback and an educational brochure, with or without patient activation, on care received.

3. Identify barriers and facilitators to receiving appropriate care for identified adolescent depression from the perspective of adolescents, parents, and the primary care providers.

Methodology: Participants for this study will be recruited from three to four study sites in each of two cities selected from among eligible general health care settings that serve high volumes of adolescent patients, including a large community-based clinic and a set of small clinics; a high school-based health clinic; and a public/free clinic.

Specific aim 1: We will describe the impact of depression on adolescent and family functioning compared to healthy controls using a 2-group longitudinal comparison between 400 adolescents identified at baseline with major depression, and 400 adolescents with no detectable mental disorders. Primary data will be collected from three types of respondents: adolescents aged 13-17, their parents, and their health care providers. Adolescent baseline and follow-up assessments (for behavioral problems, physical health, health-related quality of life, use of psychotropic medications, etc.) will be conducted through telephone interviews supplemented by mailed questionnaires. Parents will be asked to complete baseline and follow-up assessments to determine family burden, health insurance, demographics, and the adolescent's functioning at school. Study participants will be assessed twice, 6 months apart, with an interim contact at 3 months. Primary care providers (PCPs) will complete written questionnaires that will include data on demographic characteristics, medical background and training, professional practices, as well as knowledge, attitudes and reported treatment behaviors.

Specific aim 2: We will evaluate the effect of the intervention on care received by randomizing half of the 400 adolescents with major depression to one of two conditions--Feedback and Educational Brochure, with and without Patient Activation (FPA) and then observing service use over the next 6 months. The minimal intervention consists of feedback about the diagnosis to the primary care provider, teen and parent, and also includes an educational brochure to teens and parents. In the more active FPA intervention, in addition to feedback and educational brochure, telephone calls will be made to depressed teens and their parents to discuss symptoms and alternative treatment options with the aim of encouraging help-seeking. We will compare the two groups on whether they received mental health care, what kind, and their satisfaction with that care.

Specific aim 3: For the 400 depressed teens in the study, we will conduct a descriptive analysis of the preferences for treatment, barriers encountered, and use of services. We will obtain this information from the teens', parents', and providers' perspectives in order to identify barriers and facilitators to receiving appropriate care.

Eligibility

Ages Eligible for Study:  13 Years   -   17 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Between the ages of 13-17
  • Attending School
  • Living with parent or guardian
  • Reads and writes English
  • Receiving care at a participating PCP office

Exclusion Criteria:

  • Pregnancy
  • Parents don't speak English or Spanish

Location and Contact Information

Audrey Burnam, PhD      (310) 393-0411  Ext. 6370    Audrey_Burnam@rand.org
Lisa Jaycox, PhD      (310) 393-0411  Ext. 5118    Lisa_Jaycox@rand.org

California
      Northeast Valley Health Corporation-San Fernando Valley High School, San Fernando,  California,  91340,  United States; Recruiting
Jan Marquard  818-898-3390    Jan.Marquard@csun.edu 
Brian Flame  (818) 837-3402    BrianFlame@nevhc.org 
Audrey Burnam, PhD,  Principal Investigator

      Family Care Specialists at White Memorial Medical Center, Los Angeles,  California,  90033,  United States; Recruiting
Rosina Franco, MD  323-317-9200  Ext. 232    rfranco@fcsmg.com 
Gerardo Rodriguez  323-317-9200  Ext. 219    grodriguez@fcsmg.com 
Audrey Burnam, PhD,  Principal Investigator

District of Columbia
      Children's National Medical Center Adolescent Health Clinic, Washington,  District of Columbia,  20010,  United States; Not yet recruiting
Larry D'Angelo, MD  202-884-2178    ldangelo@cnmc.org 
Angela Ellis  202-884-2178    aellis@cnmc.org 
Audrey Burnam, PhD,  Principal Investigator

      Children's Pediatricians and Associates, Washington,  District of Columbia,  20037,  United States; Not yet recruiting
Ellie Hamburger, MD  202-833-4543    ehamburg@cnmc.org 
Tonya Brooks  202-833-5073    tbrooks@cnmc.org 
Audrey Burnam, PhD,  Principal Investigator

Maryland
      Capital Medical Group, Chevy Chase,  Maryland,  20815,  United States; Not yet recruiting
Richard L Jones, MD  301-907-3960 
Kathy F. McCue, CRNP  301-907-3960    katlinka@aol.com 
Audrey Burnam, PhD,  Principal Investigator

      Kaiser Mid-Atlantic, Rockville,  Maryland,  20852,  United States; Not yet recruiting
Mark H Snyder  301-816-6614    mark.h.snyder@kp.org 
Debbie Conley  301-816-6419    debbie.conley@kp.org 
Audrey Burnam, PhD,  Principal Investigator

      Kaiser Mid-Atlantic-Camp Springs, Temple Hills,  Maryland,  20748,  United States; Not yet recruiting
Tami R Collins, MD  866-530-8778    Tami.R.Collins@kp.org 
Jackie D McGruder  866-530-8778    Jackie.d.mcgruder@kp.org 
Audrey Burnam, PhD,  Principal Investigator

      Kaiser Mid-Atlantic, Kensington,  Maryland,  20895,  United States; Not yet recruiting
Sima H Bakalian, MD  301-929-7211    sima.h.bakalian@kp.org 
Sandra Jones  301-929-7100 
Audrey Burnam, PhD,  Principal Investigator

Study chairs or principal investigators

Audrey Burnam, PhD,  Principal Investigator,  RAND   

More Information

Study ID Numbers:  TDAP2
Record last reviewed:  December 2004
Last Updated:  December 20, 2004
Record first received:  December 20, 2004
ClinicalTrials.gov Identifier:  NCT00099827
Health Authority: United States: Institutional Review Board (Awaiting confirmation)
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Postpartum Depression.

October 13, 2008



Page Updated: October 1, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.